tiprankstipranks
Apimeds Pharmaceuticals US, Inc. (APUS)
XASE:APUS
US Market

Apimeds Pharmaceuticals US, Inc. (APUS) Ownership - Who Owns Apimeds Pharmaceuticals US, Inc.?

16 Followers

Apimeds Pharmaceuticals US, Inc. (APUS) Ownership Overview

11.08%0.86%1.82%0.34%85.91%
11.08% Insiders
1.82% Other Institutional Investors
0.34% ETFs
85.91% Public Companies and
Individual Investors
The ownership structure of Apimeds Pharmaceuticals US, Inc. (APUS) stock is a mix of institutional, retail, and individual investors. Approximately 3.02% of the company’s stock is owned by Institutional Investors, 11.08% is owned by Insiders, and 85.91% is owned by Public Companies and Individual Investors.
The ownership structure of Apimeds Pharmaceuticals US, Inc. (APUS) stock is a mix of institutional, retail, and individual investors. Approximately 2.67% of the company’s stock is owned by Institutional Investors, 11.08% is owned by Insiders, and 0.34% is owned by Public Companies and Individual Investors.

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
750,000Insider4.97%675,000
643,885Insider4.27%579,497
277,500Insider1.84%249,750
60,976Institution0.40%54,878
51,620Institution0.34%46,458
34,953Institution0.23%31,458
33,479Institution0.22%30,131

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
60,976Institution0.40%54,878
34,953Institution0.23%31,458
33,479Institution0.22%30,131

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
51,620Institution0.34%72,784

FAQ

Who Owns Apimeds Pharmaceuticals US, Inc. (APUS)?
According to the latest TipRanks data, approximately 1.82% of the company's stock is held by institutional investors, 11.08% is held by insiders, and 85.91% is held by retail investors.
    What percentage of Apimeds Pharmaceuticals US, Inc. (APUS) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 1.82% of Apimeds Pharmaceuticals US, Inc. (APUS) stock is held by institutional investors.
      What percentage of Apimeds Pharmaceuticals US, Inc. (APUS) stock is held by retail investors?
      According to the latest TipRanks data, approximately 85.91% of Apimeds Pharmaceuticals US, Inc. (APUS) stock is held by retail investors.
        Who owns the most shares of Apimeds Pharmaceuticals US, Inc. (APUS)?
        Emerson Erik C. owns the most shares of Apimeds Pharmaceuticals US, Inc. (APUS).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.